Tectonic Therapeutic | AVRO - Market Capitalization

Stock Price
21.35
Daily Change
0.16 0.76%
Monthly
10.74%
Yearly
-19.77%
Q1 Forecast
20.71

Tectonic Therapeutic reported $312.6M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 322M 180M Jun/2025
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Celltrion KRW 40.04T 3.19T Sep/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Divis Laboratories Ltd INR 1.62T 72.34B Feb/2026
Gilead Sciences USD 183.59B 31.31B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Laboratorios Farma EUR 3.68B 430.05M Jan/2026
MacroGenics USD 114M 8M Feb/2026
Malin Corporation EUR 150.45M 12.13M Jan/2026
Medical Developments International AUD 61.96M 16.34M Jun/2025
Neuren Pharmaceuticals AUD 1.75B 152.5M Jun/2025
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Ovoca Bio EUR 7.54M 4.28M Jun/2022
Pfizer USD 152.89B 11.32B Feb/2026
Pharma Mar EUR 1.63B 241.7M Sep/2025
Qiagen NV USD 9.46B 440.29M Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Sartorius EUR 8.12B 8.29B Feb/2026
Sino Biopharmaceutical CNY 90.06B 33.55B Jun/2025
Takeda JPY 7.64T 774.9B Dec/2025
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025